skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 111  for All Library Resources

Results 1 2 3 4 5 next page
Show only
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Overview of Castleman disease
Material Type:
Article
Add to My Research

Overview of Castleman disease

Blood, 2020-04, Vol.135 (16), p.1353-1364 [Peer Reviewed Journal]

2020 American Society of Hematology ;2020 by The American Society of Hematology. ;ISSN: 0006-4971 ;EISSN: 1528-0020 ;DOI: 10.1182/blood.2019000931 ;PMID: 32106302

Full text available

2
Novel insights and therapeutic approaches in idiopathic multicentric Castleman disease
Material Type:
Article
Add to My Research

Novel insights and therapeutic approaches in idiopathic multicentric Castleman disease

Blood, 2018-11, Vol.132 (22), p.2323-2330 [Peer Reviewed Journal]

2018 American Society of Hematology ;2018 by The American Society of Hematology. ;2018 by The American Society of Hematology 2018 ;ISSN: 0006-4971 ;EISSN: 1528-0020 ;DOI: 10.1182/blood-2018-05-848671 ;PMID: 30487129

Full text available

3
International, evidence-based consensus diagnostic criteria for HHV-8–negative/idiopathic multicentric Castleman disease
Material Type:
Article
Add to My Research

International, evidence-based consensus diagnostic criteria for HHV-8–negative/idiopathic multicentric Castleman disease

Blood, 2017-03, Vol.129 (12), p.1646-1657 [Peer Reviewed Journal]

2017 American Society of Hematology ;2017 ;ISSN: 0006-4971 ;EISSN: 1528-0020 ;DOI: 10.1182/blood-2016-10-746933 ;PMID: 28087540

Full text available

4
Identifying and targeting pathogenic PI3K/AKT/mTOR signaling in IL-6-blockade-refractory idiopathic multicentric Castleman disease
Material Type:
Article
Add to My Research

Identifying and targeting pathogenic PI3K/AKT/mTOR signaling in IL-6-blockade-refractory idiopathic multicentric Castleman disease

The Journal of clinical investigation, 2019-10, Vol.129 (10), p.4451-4463 [Peer Reviewed Journal]

COPYRIGHT 2019 American Society for Clinical Investigation ;COPYRIGHT 2019 American Society for Clinical Investigation ;Copyright American Society for Clinical Investigation Oct 2019 ;2019 American Society for Clinical Investigation 2019 American Society for Clinical Investigation ;ISSN: 0021-9738 ;EISSN: 1558-8238 ;DOI: 10.1172/jci126091 ;PMID: 31408438

Full text available

5
Clinical and pathological characteristics of HIV- and HHV-8–negative Castleman disease
Material Type:
Article
Add to My Research

Clinical and pathological characteristics of HIV- and HHV-8–negative Castleman disease

Blood, 2017-03, Vol.129 (12), p.1658-1668 [Peer Reviewed Journal]

2017 American Society of Hematology ;2017 ;ISSN: 0006-4971 ;EISSN: 1528-0020 ;DOI: 10.1182/blood-2016-11-748855 ;PMID: 28100459

Full text available

6
A model for crowdsourcing high-impact research questions for Castleman disease and other rare diseases
Material Type:
Article
Add to My Research

A model for crowdsourcing high-impact research questions for Castleman disease and other rare diseases

Orphanet journal of rare diseases, 2023-04, Vol.18 (1), p.75-75, Article 75 [Peer Reviewed Journal]

2023. The Author(s). ;COPYRIGHT 2023 BioMed Central Ltd. ;2023. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2023 ;ISSN: 1750-1172 ;EISSN: 1750-1172 ;DOI: 10.1186/s13023-023-02678-6 ;PMID: 37041585

Full text available

7
Novel insights and therapeutic approaches in idiopathic multicentric Castleman disease
Material Type:
Article
Add to My Research

Novel insights and therapeutic approaches in idiopathic multicentric Castleman disease

Hematology, 2018-11, Vol.2018 (1), p.318-325

2018 by The American Society of Hematology. All rights reserved. ;2018 by The American Society of Hematology. All rights reserved. 2018 American Society of Hematology ;ISSN: 1520-4391 ;EISSN: 1520-4383 ;DOI: 10.1182/asheducation-2018.1.318 ;PMID: 30504327

Full text available

8
Increased mTOR activation in idiopathic multicentric Castleman disease
Material Type:
Article
Add to My Research

Increased mTOR activation in idiopathic multicentric Castleman disease

Blood, 2020-05, Vol.135 (19), p.1673-1684 [Peer Reviewed Journal]

2020 American Society of Hematology ;2020 by The American Society of Hematology. ;2020 by The American Society of Hematology 2020 ;ISSN: 0006-4971 ;EISSN: 1528-0020 ;DOI: 10.1182/blood.2019002792 ;PMID: 32206779

Full text available

9
CXCL13 is a predictive biomarker in idiopathic multicentric Castleman disease
Material Type:
Article
Add to My Research

CXCL13 is a predictive biomarker in idiopathic multicentric Castleman disease

Nature communications, 2022-11, Vol.13 (1), p.7236-7236, Article 7236 [Peer Reviewed Journal]

2022. The Author(s). ;The Author(s) 2022. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2022 ;ISSN: 2041-1723 ;EISSN: 2041-1723 ;DOI: 10.1038/s41467-022-34873-7 ;PMID: 36433996

Full text available

10
Sharing is caring: a call for a new era of rare disease research and development
Material Type:
Article
Add to My Research

Sharing is caring: a call for a new era of rare disease research and development

Orphanet journal of rare diseases, 2022-10, Vol.17 (1), p.389-389, Article 389 [Peer Reviewed Journal]

2022. The Author(s). ;COPYRIGHT 2022 BioMed Central Ltd. ;2022. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1750-1172 ;EISSN: 1750-1172 ;DOI: 10.1186/s13023-022-02529-w ;PMID: 36303170

Full text available

11
Cytokine Storm
Material Type:
Article
Add to My Research

Cytokine Storm

New England Journal of Medicine, 2020-12, Vol.383 (23), p.2255-2273 [Peer Reviewed Journal]

Copyright © 2020 Massachusetts Medical Society. All rights reserved. ;2020. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.nejm.org/about-nejm/permissions?query=footer ;Copyright © 2020 Massachusetts Medical Society. All rights reserved. 2020 Massachusetts Medical Society ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMra2026131 ;PMID: 33264547

Digital Resources/Online E-Resources

12
International evidence-based consensus diagnostic and treatment guidelines for unicentric Castleman disease
Material Type:
Article
Add to My Research

International evidence-based consensus diagnostic and treatment guidelines for unicentric Castleman disease

Blood advances, 2020-12, Vol.4 (23), p.6039-6050 [Peer Reviewed Journal]

2020 American Society of Hematology ;2020 by The American Society of Hematology. ;2020 by The American Society of Hematology 2020 ;ISSN: 2473-9529 ;EISSN: 2473-9537 ;DOI: 10.1182/bloodadvances.2020003334 ;PMID: 33284946

Full text available

13
Quantitative analysis of a rare disease network's international contact database and E-repository provides insights into biobanking in the electronic consent era
Material Type:
Article
Add to My Research

Quantitative analysis of a rare disease network's international contact database and E-repository provides insights into biobanking in the electronic consent era

Orphanet journal of rare diseases, 2019-07, Vol.14 (1), p.173-173, Article 173 [Peer Reviewed Journal]

COPYRIGHT 2019 BioMed Central Ltd. ;COPYRIGHT 2019 BioMed Central Ltd. ;The Author(s). 2019 ;ISSN: 1750-1172 ;EISSN: 1750-1172 ;DOI: 10.1186/s13023-019-1145-y ;PMID: 31296233

Full text available

14
Correction to: Sharing is caring: a call for a new era of rare disease research and development
Material Type:
Article
Add to My Research

Correction to: Sharing is caring: a call for a new era of rare disease research and development

Orphanet journal of rare diseases, 2023-01, Vol.18 (1), p.15-15, Article 15 [Peer Reviewed Journal]

COPYRIGHT 2023 BioMed Central Ltd. ;2023. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2023 ;ISSN: 1750-1172 ;EISSN: 1750-1172 ;DOI: 10.1186/s13023-023-02613-9 ;PMID: 36691034

Full text available

15
Virome capture sequencing does not identify active viral infection in unicentric and idiopathic multicentric Castleman disease
Material Type:
Article
Add to My Research

Virome capture sequencing does not identify active viral infection in unicentric and idiopathic multicentric Castleman disease

PloS one, 2019-06, Vol.14 (6), p.e0218660-e0218660 [Peer Reviewed Journal]

COPYRIGHT 2019 Public Library of Science ;2019 Nabel et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2019 Nabel et al 2019 Nabel et al ;ISSN: 1932-6203 ;EISSN: 1932-6203 ;DOI: 10.1371/journal.pone.0218660 ;PMID: 31242229

Full text available

16
Optimisation of anti-interleukin-6 therapy: Precision medicine through mathematical modelling
Material Type:
Article
Add to My Research

Optimisation of anti-interleukin-6 therapy: Precision medicine through mathematical modelling

Frontiers in immunology, 2022-07, Vol.13, p.919489-919489 [Peer Reviewed Journal]

Copyright © 2022 Rossi, Chiang, Lu, Levon, van Rhee, Kanhai, Fajgenbaum and Klein. ;Attribution ;Copyright © 2022 Rossi, Chiang, Lu, Levon, van Rhee, Kanhai, Fajgenbaum and Klein 2022 Rossi, Chiang, Lu, Levon, van Rhee, Kanhai, Fajgenbaum and Klein ;ISSN: 1664-3224 ;EISSN: 1664-3224 ;DOI: 10.3389/fimmu.2022.919489 ;PMID: 35928820

Full text available

17
Siltuximab: a targeted therapy for idiopathic multicentric Castleman disease
Material Type:
Article
Add to My Research

Siltuximab: a targeted therapy for idiopathic multicentric Castleman disease

Immunotherapy, 2016-01, Vol.8 (1), p.17-26 [Peer Reviewed Journal]

Future Medicine Ltd ;Copyright Future Medicine Ltd Jan 2016 ;ISSN: 1750-743X ;EISSN: 1750-7448 ;DOI: 10.2217/imt.15.95 ;PMID: 26634298

Full text available

18
Effectiveness of rituximab-containing treatment regimens in idiopathic multicentric Castleman disease
Material Type:
Article
Add to My Research

Effectiveness of rituximab-containing treatment regimens in idiopathic multicentric Castleman disease

Annals of hematology, 2018-09, Vol.97 (9), p.1641-1647 [Peer Reviewed Journal]

Springer-Verlag GmbH Germany, part of Springer Nature 2018 ;Annals of Hematology is a copyright of Springer, (2018). All Rights Reserved. ;ISSN: 0939-5555 ;EISSN: 1432-0584 ;DOI: 10.1007/s00277-018-3347-0 ;PMID: 29732477

Full text available

19
Potential value of FDG PET-CT in diagnosis and follow-up of TAFRO syndrome
Material Type:
Article
Add to My Research

Potential value of FDG PET-CT in diagnosis and follow-up of TAFRO syndrome

Annals of hematology, 2017-03, Vol.96 (3), p.497-500 [Peer Reviewed Journal]

Springer-Verlag Berlin Heidelberg 2016 ;Annals of Hematology is a copyright of Springer, 2017. ;ISSN: 0939-5555 ;EISSN: 1432-0584 ;DOI: 10.1007/s00277-016-2875-8 ;PMID: 27853835

Full text available

20
Treatments Administered to the First 9152 Reported Cases of COVID-19: A Systematic Review
Material Type:
Article
Add to My Research

Treatments Administered to the First 9152 Reported Cases of COVID-19: A Systematic Review

Infectious diseases and therapy, 2020-09, Vol.9 (3), p.435-449 [Peer Reviewed Journal]

The Author(s) 2020 ;The Author(s) 2020. This work is published under http://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 2193-8229 ;EISSN: 2193-6382 ;DOI: 10.1007/s40121-020-00303-8 ;PMID: 32462545

Full text available

Results 1 - 20 of 111  for All Library Resources

Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Show only

  1. Peer-reviewed Journals (100)

Refine My Results

Creation Date 

From To
  1. Before 2015  (3)
  2. 2015 To 2016  (3)
  3. 2017 To 2018  (22)
  4. 2019 To 2021  (44)
  5. After 2021  (40)
  6. More options open sub menu

Resource Type 

  1. Articles  (105)
  2. Reports  (4)
  3. Conference Proceedings  (1)
  4. Patents  (1)
  5. More options open sub menu

Language 

  1. Japanese  (19)
  2. Norwegian  (1)
  3. More options open sub menu

Searching Remote Databases, Please Wait